EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Incidental Findings From Treatment Response Monitoring in Oncological Care: Ethical Reflections

Jasper Debrabander iD, Stefano Fanti, Elisabetta Lalumera iD

Bioethics · 20.08.2026

DOI: 10.1111/bioe.70167 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioethics, online erschienen am 20.08.2026. Verfasst von Jasper Debrabander und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department Healthcare, PXL University College, Hasselt, Belgium. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The question of how to handle incidental findings in medicine has attracted a lot of attention in the bioethics literature. The most widely discussed examples come from genetics (e.g., next generation sequencing) and medical imaging (e.g., neuroimaging). While incidental findings in medical imaging research have sparked much debate, the way incidental findings arising from medical imaging are handled in clinical practice is taken to be relatively uncontentious. However, in this paper, I will challenge how incidental findings arising from treatment response monitoring in oncological care are handled. At present, oncological patients' consent is not obtained before disclosing incidental findings that arise during treatment response monitoring. Rather, all and only incidental findings that are taken to be clinically relevant are disclosed. Using treatment response monitoring in metastatic breast cancer care as an illustration throughout the paper, I will challenge the more general practice of not offering oncological patients the possibility to refuse being informed about incidental findings that arise during treatment response monitoring. Ultimately, I will argue for the introduction of a tiered‐layered‐staged consent regarding the disclosure of incidental findings before the initiation of treatment response monitoring in oncological care for much the same reasons as it has been advocated for in genetics.

Autor:innen und Institutionen

  • Department Healthcare, PXL University College, Hasselt, Belgium.
  • Department of Philosophy and Moral Sciences, Ghent University, Ghent, Belgium.
  • Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Department for Life Quality Studies, University of Bologna, Rimini, Italy.
  • Centre for Philosophy of Epidemiology, Medicine, and Public Health, University of Johannesburg, Johannesburg, South Africa.

ORCID-Profile: Jasper Debrabander, Elisabetta Lalumera

Zitieren

APA

Debrabander, J., Fanti, S., & Lalumera, E. (2026). Incidental Findings From Treatment Response Monitoring in Oncological Care: Ethical Reflections. Bioethics. https://doi.org/10.1111/bioe.70167

Vancouver

Debrabander J, Fanti S, Lalumera E. Incidental Findings From Treatment Response Monitoring in Oncological Care: Ethical Reflections. Bioethics. 2026. doi:10.1111/bioe.70167

BibTeX
@article{Debrabander2026,
  author = {Debrabander, Jasper and Fanti, Stefano and Lalumera, Elisabetta},
  title = {Incidental Findings From Treatment Response Monitoring in Oncological Care: Ethical Reflections},
  journal = {Bioethics},
  year = {2026},
  doi = {10.1111/bioe.70167}
}
Kostenlos starten →